• The immediate proposal of these animals is used in the medical sector for the transplantation of organs to persons with alpha-gal syndrome; the commercialization of this carne, although not the main objective, it additionally comes as a niche of business.
From the Administration of Medicines in Food of the United States (FCA) informs the approval of a genetically modified cadre, which we consider completely safe so much for the production of corn as for the implementation in human medicine.
The animal developed by the company Revivicor, a subsidiary of the biotechnology firm United Therapeutics Corp, is characterized by the fact that in its system does not develop the denominated alpha-gal, known by derivatives in allergic reactions.
Agreed with the express by the FDA, this it is the first time that a genetically modified animal is approved for both purposes; of 2015 the salmon is certified, but only for consumption.
THE INITIAL INFO OF THE HUMAN HEALTH, PERO IT IS POSSIBLE THE MERCHANT
In the governing body’s agency, we ensure that the ingestion of these hardy chickens — called GalSafe varke — does not contain any adverse effect on the health of individuals because what he is selling to the public is possible.
In United Therapeutics Corp. expresses for the British diary The Guardian, that the proposal of the patients, at the moment, is is approved for organ transplantation in patients with alpha-gal syndrome, a food allergy to red caraway.
Add to that the fact that if you have no plans to sell directly the animal protein generated through these cereals, are looking for alliances potentials with this industry to trade the cornices.
WITH NO EXISTING SCIENTIFIC PROVISIONS QUE PROVISION IN SEGURIDAD
In the organization without fines of luxury, EE Food Safety Center. UU, explains that currently there are no tests that determine that the consumption of this meat is safe for people with allergies, lo cual fue confirmed by United Therapeutics Corp.
Adelantaron that for this reason, will evaluate a legal claim against the FDA, considering that its issuance is contrary to the appropriate scientific foundations.